Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novartis Ag ADR (NY: NVS )

109.35 +0.95 (+0.88%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novartis Ag ADR

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
42 43 Next >
Transdermal Drug Patches Market to See Huge Growth : Novartis, Mylan, Accrux
Stay up-to-date with Transdermal Drug Patches Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Exposures COVID-19
Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts
To gain an edge, this is what you need to know today. 
Via Benzinga
Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle
The Centers for Medicare and Medicaid Services unveiled the first ten drugs subject to price negotiations under President Joe Biden's Inflation Reduction Act, including: 
Via Benzinga
2 Excellent Stocks to Buy and Hold Forever
These companies have solid long-term potential. 
Via The Motley Fool
2 Top Biotech Stocks to Buy Right Now
These drugmakers are among the most dominant in the world. 
Via The Motley Fool
DTx Pharma Acquisition by Novartis Generates Robust Returns for Tech Coast Angels and NuFund Venture Group
IRVINE, Calif. - Aug. 3, 2023 - PRLog -- Tech Coast Angels (TCA) and NuFund Venture Group (formerly TCA-San Diego) today announced that portfolio company DTx Pharma was acquired by Swiss pharmaceutical... 
Via PRLog
Blockbusters From AbbVie, Merck, Lilly Highlight List Of 10 Drugs Subject To Price Cuts
The Biden administration is planning to negotiate the prices of 10 drugs in 2026. 
Via Investor's Business Daily
3 AI Stocks With the Potential to Transform Your Financial Future
Are you looking to invest in AI stocks? Here are three picks with the potential to transform your financial future. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Emerging Market Stocks to Buy in August
These three emerging market stocks to buy in August will have very strong, positive catalysts going forward. 
Via InvestorPlace
Exelixis' Lead Cancer Treatment Delivers Another Surprise, Though Analyst Finds Commercial Opportunity In Pancreatic Neuroendocrine Modest
Thursday, Exelixis Inc (NASDAQ: EXEL) announced that the Alliance for Clinical Trials in Oncology independent Data and Safety Monitoring Board (DSMB) unanimously recommended to unblind and stop the... 
Via Benzinga
Cheaper Version Of Blockbuster Arthritis Treatment Humira - CVS Health Teams With Sandoz
CVS Health Corp (NYSE: CVS) has launched Cordavis, a wholly-owned subsidiary, to work directly with manufacturers to commercialize and/or co-produce biosimilar  
Via Benzinga
Could This Medicine Be the Next Winner for Novartis?
The Swiss drugmaker recently reported that a drug candidate met the primary endpoints in phase 3 clinical trials. 
Via The Motley Fool
Gold Rush In Weight Loss Industry Impacts Retailers With Pharmacy Businesses
Retailers with pharmacy businesses, including major players like Walmart Inc (NYSE: WMT), Kroger Company (NYSE: KR), and Rite Aid Corp (NYSE: 
Via Benzinga
A Comprehensive Study Exploring Breast Cancer Drugs Market : Key Players- Sanofi, Novartis, Lilly
The Global Breast Cancer Drugs Market offers energetic visions to conclude market size, opportunities, growth pattern, and competitive surroundings. The research is derived through primary and... 
Via SBWire
Why This Regeneron Approval 'Could Not Come Soon Enough' As Novartis Looms
The FDA signed off on Regeneron's high-dose Eylea about two months earlier than expected. 
Via Investor's Business Daily
Exposures Product Safety
SpaceX On Par With Intel, Disney; US Weight Loss Drugs Pricier; Moderna, Pfizer's Shot Effective Against New Variant: Today's Top Stories
Benzinga 
Via Benzinga
Merck Reveals Mixed Results From Pivotal Kidney Cancer Study Of Welireg In Pretreated Patients
Merck & Co Inc (NYSE: MRK) released topline results from LITESPARK-005, a Phase 3 trial investigating WELIREG (belzutifan), Merck's oral hypoxia-inducible  
Via Benzinga
Novartis' Generic Business Spinoff: Plans Sandoz Spin-Off In Early October, Proposes Share Distribution
Novartis AG (NYSE: NVS)  
Via Benzinga
COPD & Asthma Devices Market to Witness Remarkable Growth by 2029 : Pfizer, GSK, Novartis, Merck
Stay up to date with COPD & Asthma Devices Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Addiction Treatment Market May See New Emerging Trends: Novartis, Pfizer, Sanofi
Pune, Maharashtra -- (SBWIRE) -- 08/17/2023 -- 2023-2031 Report on Global Addiction Treatment Market by Player, Region, Type, Application and Sales Channel is the latest research study released by HTF... 
Via SBWire
Essential Thrombocythemia Market Projected to Show Strong Growth : Pharmaessentia, Bristol Myers Squibb, Shire
Get an extensive Essential Thrombocythemia Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
3 Unstoppable Dividend Stocks to Buy Right Now
These stocks' dividends are more dependable than most. 
Via The Motley Fool
Immuno Oncology Market May See a Big Move : AstraZeneca, Bristol Myers Squibb, F. Hoffmann-La Roche
Stay up-to-date with Immuno Oncology Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Novartis's Remibrutinib Shows Rapid Improvement In Type Of Skin Disorder That Impacts 40M People
Novartis AG (NYSE: NVS)  
Via Benzinga
Hypertrophic Cardiomyopathy Therapeutics Market Projected to Show Strong Growth : Novartis, Gilead Sciences, ADVANZ PHARMA
Stay up-to-date with Hypertrophic Cardiomyopathy Therapeutics Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Multiple Myeloma Therapy Market Projected to Show Strong Growth : Hikma Pharmaceutical, Eagle Pharmaceuticals, Janssen Biotech
Get Multiple Myeloma Therapy Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis. 
Via SBWire
The Year’s Top 3 International ETFs as of August 2023
By investing in international ETFs, you can mitigate potential losses with a more diversified portfolio. Here are three with strong returns. 
Via InvestorPlace
Blockbuster Drugs Market Projected to Show Strong Growth : Celgene, Bristol-Myers Squibb, Pfizer
Get an extensive Blockbuster Drugs Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
Topics Intellectual Property
Exposures Intellectual Property
7 Best Cancer Stocks to Invest in Now
The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now. 
Via MarketBeat
Topics Death
Exposures Death
3 Biotech Stocks You Better Be Buying on Each and Every Dip
Biotech companies can bring about life-changing innovations. We've created a list to help you find the best biotech stocks out there. 
Via InvestorPlace
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
42 43 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback